Natural products and phytochemicals as potential anti-SARS-CoV-2 drugs.

Myriam Merarchi, Namrata Dudha, Bhudev C Das, Manoj Garg
Author Information
  1. Myriam Merarchi: Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  2. Namrata Dudha: Department of Biotechnology and Microbiology, School of Sciences, Noida International University, Gautam Budh Nagar, India.
  3. Bhudev C Das: Amity Institute of Molecular Medicine and Stem cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida, India.
  4. Manoj Garg: Amity Institute of Molecular Medicine and Stem cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida, India. ORCID

Abstract

The current pandemic responsible for the crippling of the health care system is caused by the novel SARS-CoV-2 in 2019 and leading to coronavirus disease 2019 (COVID-19). The virus enters into humans by attachment of its Spike protein (S) to the ACE receptor present on the lung epithelial cell surface followed by cleavage of S protein by the cellular transmembrane serine protease (TMPRSS2). After entry, the SARS-CoV-2 RNA genome is released into the cytosol, where it highjacks host replication machinery for viral replication, assemblage, as well as the release of new viral particles. The major drug targets that have been identified for SARS-CoV-2 through host-virus interaction studies include 3CLpro, PLpro, RNA-dependent RNA polymerase, and S proteins. Several reports of natural compounds along with synthetic products have displayed promising results and some of them are Tripterygium wilfordii, Pudilan Xiaoyan Oral Liquid, Saponin derivates, Artemisia annua, Glycyrrhiza glabra L., Jinhua Qinggan granules, Xuebijing, and Propolis. This review attempts to disclose the natural products identified as anti-SARS-CoV-2 based on in silico prediction and the effect of a variety of phytochemicals either alone and/or in combination with conventional treatments along with their possible molecular mechanisms involved for both prevention and treatment of the SARS-CoV-2 disease.

Keywords

References

  1. J Adv Res. 2020 Mar 16;24:91-98 [PMID: 32257431]
  2. Semin Cancer Biol. 2017 Oct;46:65-83 [PMID: 28254675]
  3. Phytother Res. 2020 Oct;34(10):2423-2424 [PMID: 32424845]
  4. Pulm Med. 2020 Aug 10;2020:6175964 [PMID: 32850151]
  5. Nature. 2020 Mar;579(7798):270-273 [PMID: 32015507]
  6. Biomed Pharmacother. 2020 Nov;131:110622 [PMID: 32890967]
  7. Am J Clin Pathol. 2020 Mar 9;153(4):420-421 [PMID: 32053148]
  8. Evid Based Complement Alternat Med. 2012;2012:157652 [PMID: 23320022]
  9. Microbiol Mol Biol Rev. 2005 Dec;69(4):635-64 [PMID: 16339739]
  10. Lancet. 2020 Feb 22;395(10224):565-574 [PMID: 32007145]
  11. Infez Med. 2020 Ahead of print Jun 1;28(2):174-184 [PMID: 32275259]
  12. Phytochem Rev. 2020;19(1):1-61 [PMID: 32206048]
  13. Circ Res. 2020 May 8;126(10):1456-1474 [PMID: 32264791]
  14. Indian J Pharmacol. 2020 Jan-Feb;52(1):56-65 [PMID: 32201449]
  15. Antiviral Res. 2020 Jun;178:104792 [PMID: 32272173]
  16. Antiviral Res. 2013 Dec;100(3):605-14 [PMID: 24121034]
  17. Phytother Res. 2021 Feb;35(2):864-876 [PMID: 32985017]
  18. World J Nephrol. 2015 Feb 6;4(1):74-82 [PMID: 25664248]
  19. Front Pharmacol. 2018 Jan 31;9:49 [PMID: 29445341]
  20. Molecules. 2015 Feb 05;20(2):2728-69 [PMID: 25665066]
  21. Phytother Res. 2020 Nov;34(11):2911-2920 [PMID: 32430996]
  22. PLoS One. 2013 May 01;8(5):e62482 [PMID: 23658730]
  23. Biophys Chem. 2020 Oct;265:106438 [PMID: 32721790]
  24. Cell Res. 2021 Apr;31(4):395-403 [PMID: 33603116]
  25. Signal Transduct Target Ther. 2020 May 8;5(1):66 [PMID: 32385228]
  26. Front Pharmacol. 2018 Nov 15;9:1276 [PMID: 30498444]
  27. Crit Care Med. 2019 Sep;47(9):e735-e743 [PMID: 31162191]
  28. Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1213-1218 [PMID: 32281327]
  29. Phytother Res. 2020 Oct;34(10):2471-2492 [PMID: 32248575]
  30. Medicine (Baltimore). 2020 Jun 12;99(24):e20612 [PMID: 32541495]
  31. Antioxid Redox Signal. 2008 Feb;10(2):355-70 [PMID: 17999627]
  32. Cell. 2020 Apr 16;181(2):281-292.e6 [PMID: 32155444]
  33. Mar Drugs. 2020 Apr 23;18(4): [PMID: 32340389]
  34. Virol J. 2019 May 27;16(1):69 [PMID: 31133031]
  35. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Oct;31(10):1199-1203 [PMID: 31771714]
  36. Phytother Res. 2008 Feb;22(2):141-8 [PMID: 17886224]
  37. Free Radic Biol Med. 2007 Aug 15;43(4):568-80 [PMID: 17640567]
  38. Biomed Res Int. 2017;2017:2418671 [PMID: 28546962]
  39. J Biol Chem. 2009 Aug 28;284(35):23177-81 [PMID: 19487698]
  40. Biomed Res Int. 2020 May 30;2020:4389089 [PMID: 32596311]
  41. Phytother Res. 2021 Mar;35(3):1298-1312 [PMID: 33037698]
  42. J Ethnopharmacol. 2020 Apr 24;252:112496 [PMID: 31870795]
  43. Adv Virus Res. 2006;66:193-292 [PMID: 16877062]
  44. J Infect Public Health. 2020 Nov;13(11):1671-1677 [PMID: 33008777]
  45. Nat Rev Cardiol. 2020 May;17(5):313 [PMID: 32231328]
  46. Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1219-1224 [PMID: 32281328]
  47. Evid Based Complement Alternat Med. 2013;2013:418508 [PMID: 23690844]
  48. Life Sci. 2020 Aug 15;255:117831 [PMID: 32450166]
  49. Mar Drugs. 2017 Feb 21;15(2): [PMID: 28230766]
  50. Clin Exp Pharmacol Physiol. 2006 Jul;33(7):612-6 [PMID: 16789928]
  51. Science. 2003 Jun 13;300(5626):1763-7 [PMID: 12746549]
  52. Sci Rep. 2020 Oct 19;10(1):17699 [PMID: 33077836]
  53. Plant Cell. 1997 Oct;9(10):1767-1780 [PMID: 12237347]
  54. J Struct Biol. 2011 Apr;174(1):11-22 [PMID: 21130884]
  55. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):426-429 [PMID: 32527346]
  56. Cell Death Dis. 2018 May 22;9(6):601 [PMID: 29789558]
  57. Phytother Res. 2021 Mar;35(3):1230-1236 [PMID: 33034398]
  58. Zhongguo Zhong Yao Za Zhi. 2020 May;45(10):2249-2256 [PMID: 32495577]
  59. J Integr Med. 2020 Mar;18(2):152-158 [PMID: 32113846]
  60. Phytother Res. 2020 Jun;34(6):1189-1190 [PMID: 32347602]
  61. Biomed Res Int. 2014;2014:186864 [PMID: 24877064]
  62. Science. 2020 Apr 24;368(6489):409-412 [PMID: 32198291]
  63. J Med Virol. 2020 Apr;92(4):418-423 [PMID: 31967327]
  64. Front Pharmacol. 2020 Oct 16;11:588508 [PMID: 33178026]
  65. Phytother Res. 2020 Sep;34(9):2085-2087 [PMID: 32442323]
  66. Lancet. 2020 Feb 15;395(10223):497-506 [PMID: 31986264]
  67. Med J Aust. 2020 Jul;213(2):54-56.e1 [PMID: 32572965]
  68. Trials. 2020 Sep 15;21(1):790 [PMID: 32933552]
  69. Phytother Res. 2021 Oct;35(10):5384-5396 [PMID: 34132421]
  70. Eur J Pharmacol. 2021 Jan 5;890:173648 [PMID: 33069672]
  71. Lancet. 2003 Jun 14;361(9374):2045-6 [PMID: 12814717]
  72. J Virol. 2019 Mar 5;93(6): [PMID: 30626688]
  73. Phytother Res. 2020 Dec;34(12):3124-3136 [PMID: 32468635]
  74. Science. 2020 Jul 17;369(6501):330-333 [PMID: 32366695]
  75. Phytother Res. 2021 Apr;35(4):1683-1685 [PMID: 33368721]
  76. Mol Cell Biol. 2006 Feb;26(3):965-75 [PMID: 16428450]
  77. Zhongguo Zhong Yao Za Zhi. 2020 May;45(10):2257-2264 [PMID: 32495578]
  78. J Crit Care. 2020 Jun;57:279-283 [PMID: 32173110]
  79. Int J Biol Macromol. 2020 Dec 1;164:1693-1703 [PMID: 32745548]
  80. J Virol. 1980 Jan;33(1):449-62 [PMID: 6245243]
  81. ChemistrySelect. 2020 Nov 13;5(42):13309-13317 [PMID: 33363254]
  82. Photodiagnosis Photodyn Ther. 2021 Jun;34:102286 [PMID: 33838311]
  83. Int J Clin Exp Pathol. 2017 Sep 01;10(9):9302-9309 [PMID: 31966802]
  84. Immunopharmacol Immunotoxicol. 2018 Jun;40(3):250-255 [PMID: 29493374]
  85. Cell. 2020 Apr 16;181(2):271-280.e8 [PMID: 32142651]
  86. Eur J Pharmacol. 2020 Nov 5;886:173551 [PMID: 32931783]
  87. J Cell Physiol. 2018 Jan;234(1):214-222 [PMID: 29968913]
  88. J Inflamm Res. 2021 Mar 16;14:869-884 [PMID: 33758527]
  89. Phytother Res. 2019 Apr;33(4):1191-1198 [PMID: 30768745]
  90. Phytother Res. 2021 Jun;35(6):3013-3031 [PMID: 33373071]
  91. Drug Des Devel Ther. 2015 Nov 11;9:6043-54 [PMID: 26648693]
  92. Clin Kidney J. 2021 Mar 26;14(Suppl 1):i21-i29 [PMID: 33815780]
  93. Trends Pharmacol Sci. 2004 Jun;25(6):291-4 [PMID: 15165741]
  94. Nature. 2020 May;581(7807):215-220 [PMID: 32225176]
  95. Nat Rev Cardiol. 2020 May;17(5):259-260 [PMID: 32139904]
  96. Bioorg Chem. 2020 Nov;104:104269 [PMID: 32947136]
  97. Zhongguo Zhong Yao Za Zhi. 2020 Apr;45(7):1481-1487 [PMID: 32489024]
  98. Nature. 2020 Mar;579(7798):265-269 [PMID: 32015508]
  99. Phytomedicine. 2021 May;85:153311 [PMID: 33067112]

MeSH Term

Antiviral Agents
Biological Products
Drugs, Chinese Herbal
Humans
Phytochemicals
SARS-CoV-2
COVID-19 Drug Treatment

Chemicals

Antiviral Agents
Biological Products
Drugs, Chinese Herbal
Phytochemicals
jinhua qinggan granules

Word Cloud

Created with Highcharts 10.0.0SARS-CoV-2Snaturalproductsphytochemicals2019diseaseCOVID-19proteinRNAreplicationviralidentifiedcompoundsalonganti-SARS-CoV-2preventioncurrentpandemicresponsiblecripplinghealthcaresystemcausednovelleadingcoronavirusvirusentershumansattachmentSpikeACEreceptorpresentlungepithelialcellsurfacefollowedcleavagecellulartransmembraneserineproteaseTMPRSS2entrygenomereleasedcytosolhighjackshostmachineryassemblagewellreleasenewparticlesmajordrugtargetshost-virusinteractionstudiesinclude3CLproPLproRNA-dependentpolymeraseproteinsSeveralreportssyntheticdisplayedpromisingresultsTripterygiumwilfordiiPudilanXiaoyanOralLiquidSaponinderivatesArtemisiaannuaGlycyrrhizaglabraLJinhuaQinggangranulesXuebijingPropolisreviewattemptsdisclosebasedsilicopredictioneffectvarietyeitheraloneand/orcombinationconventionaltreatmentspossiblemolecularmechanismsinvolvedtreatmentNaturalpotentialdrugsMERS-CoVRNA-VirusSARS-CoVcoronavirusestherapy

Similar Articles

Cited By